Charles River Laboratories International Earnings Preview: Can This Streak Continue?

Charles River Laboratories International (NYSE:CRL) will report earnings after markets close on Wednesday, May 1st. Charles River Laboratories International, Inc. provides research tools and support services that enable drug discovery and development. The Company provides the animal research models required in research and development for new drugs, devices, and therapies. Charles River’s customers include pharmaceutical and biotechnology companies, hospitals, and academic institutions.

Here is your Cheat Sheet to Charles River Laboratories International Earnings:

Earnings Expectations: Analysts expect earnings of $0.71 per share on revenues of $294.60 million. Currently, the company’s P/E ratio stands at 21.10.

Analyst Trends:

Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.76 to a profit $0.77. For the current year, the average estimate is a profit of $2.85, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Charles River Laboratories International has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 1,343 1,172 1,133 1,143 1,130
Diluted EPS ($) -7.76 1.74 -5.38 2.14 2.01

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 290.96 285.98 284.72 278.69 280.14
Diluted EPS ($) 0.5584 0.54 0.63 0.46 0.3821

Past Performance:
Charles River Laboratories International has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]